Stephen G. Swisher

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-3080-1920

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.359Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Impact of genomic aberrations and additional therapies on survival outcomes of patients with operable non-small cell lung cancer (NSCLC) from the NEOSTAR study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8542

Top 49%

0.359DataRank

Top 49%3 citations

Boris Sepesi, Cheuk Hong Leung, Heather Lin, William Nassib William, Annikka Weissferdt +15 more

Papers

Driven by 32 papers — median percentile 51. Top paper: “Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery”.

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

The Lancet Oncology(2021)10.1016/s1470-2045(21)00401-0

N/A

6.1DataRank · unranked

319 citations

Reza J. Mehran, Lei Feng, Vivek Verma, Zhongxing Liao, James W. Welsh +30 more

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

The Lancet(2023)10.1016/s0140-6736(23)01384-3

N/A

5.0DataRank · unranked

230 citations

Steven H. Lin, Wenli Dong, Zhongxing Liao, Saumil Gandhi, Carl M. Gay +23 more

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Nature Medicine(2023)10.1038/s41591-022-02189-0

N/A

4.1DataRank · unranked

213 citations

Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy +52 more

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-25188-0

N/A

3.1DataRank · unranked

110 citations

Annikka Weissferdt, Myrna C. B. Godoy, William N. William, Cheuk Hong Leung, Heather Lin +23 more

High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008950

N/A

0.515DataRank · unranked

13 citations

Ruoxing Li, Ziyi Li, Runzhe Chen, Ajay Sheshadri, Hai T. Tran +12 more

Impact of genomic aberrations and additional therapies on survival outcomes of patients with operable non-small cell lung cancer (NSCLC) from the NEOSTAR study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8542

Top 49%

0.359DataRank

Top 49%3 citations

Boris Sepesi, Cheuk Hong Leung, Heather Lin, William Nassib William, Annikka Weissferdt +15 more

Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events

Frontiers in Immunology(2023)10.3389/fimmu.2023.1322818

N/A

0.357DataRank · unranked

6 citations

Quan‐Zhen Li, Qi Wang, Natalie I. Vokes, Ajay Sheshadri, Jianjun Gao +14 more

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Cancer Cell(2021)10.1016/j.ccell.2020.12.014

N/A

0DataRank · unranked

945 citations

C. Allison Stewart, Elizabeth M. Park, Lixia Diao, Sarah M. Groves, Simon Heeke +25 more

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002891

N/A

0DataRank · unranked

292 citations

Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bāra, Vincent K. Shen +33 more

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Annals of Oncology(2021)10.1016/j.annonc.2021.09.021

N/A

0DataRank · unranked

137 citations

Daniel J. McGrail, Salah-Eddine Bentebibel, Cara Haymaker, Angelo Ravelli, Marie‐Andrée Forget +31 more

Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.03.029

N/A

0DataRank · unranked

47 citations

Annikka Weissferdt, Ara A. Vaporciyan, Arlene M. Correa, Boris Sepesi, Ignacio I. Wistuba +4 more

Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer

The Annals of Thoracic Surgery(2021)10.1016/j.athoracsur.2021.06.017

N/A

0DataRank · unranked

15 citations

Wayne L. Hofstetter, Reza J. Mehran, Ravi Rajaram, David C. Rice, Jack A. Roth +7 more

Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo

Blood Advances(2021)10.1182/bloodadvances.2021006156

N/A

0DataRank · unranked

8 citations

Ran Zhang, Chenghui Ren, Yi Xu, Shuhong Wu, Carrie Meng +19 more

Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients

Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery(2021)10.1177/15569845211041343

N/A

0DataRank · unranked

2 citations

Nicolas Zhou, Kavita Parikh, Wayne L. Hofstetter, Reza J. Mehran, Ravi Rajaram +7 more

The histologic phenotype of lung cancers may be driven by transcriptomic features rather than genomic characteristics

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.01.425056

N/A

0DataRank · unranked

0 citations

Hussein A. Abbas, Marcelo V. Negrão, Maheshwari Ramineni, Xin Hu, Junya Fujimoto +24 more

Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment

Lung Cancer(2022)10.1016/j.lungcan.2022.08.007

N/A

0DataRank · unranked

22 citations

Jiexin Zhang, Erin M. Bayley, Meredith Frank, Shin‐Heng Chiou, Carmen Behrens +21 more

Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100420

N/A

0DataRank · unranked

19 citations

Annikka Weissferdt, Arlene M. Correa, Ara A. Vaporciyan, Boris Sepesi, John V. Heymach +4 more

Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis

Frontiers in Cardiovascular Medicine(2022)10.3389/fcvm.2022.916325

N/A

0DataRank · unranked

4 citations

Elie Mouhayar, Juhee Song, Efstratios Koutroumpakis, Nicolas L. Palaskas, Syed Wamique Yusuf +10 more

Molecular parameters impacting the success rate of a lung cancer PDX model.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e20592

N/A

0DataRank · unranked

0 citations

Shawna M. Hubert, Ran Zhang, Xingzhi Song, Tatiana V. Karpinets, Annikka Weissferdt +15 more

Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer

Annals of Oncology(2023)10.1016/j.annonc.2023.11.008

N/A

0DataRank · unranked

71 citations

Simon Heeke, Sheeba J. Sujit, Natalie I. Vokes, J. Zhang, Muhammad Aminu +10 more

Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2023)10.1016/j.jtcvs.2023.09.073

N/A

0DataRank · unranked

21 citations

Boris Sepesi, Cheuk Hong Leung, Heather Lin, Annikka Weissferdt, Apar Pataer +15 more

Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy

Modern Pathology(2023)10.1016/j.modpat.2023.100353

N/A

0DataRank · unranked

22 citations

Cheuk Hong Leung, Heather Lin, Boris Sepesi, William N. William, Stephen G. Swisher +4 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0DataRank · unranked

165 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions

Cancer Cell(2025)10.1016/j.ccell.2025.10.004

N/A

0DataRank · unranked

19 citations

Ansam Sinjab, Yibo Dai, Warapen Treekitkarnmongkol, Sujuan Yang, Lorena I. Gomez Bolanos +44 more

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.04.026

N/A

0DataRank · unranked

194 citations

Marcelo V. Negrão, Seyedeh Dibaj, Runzhe Chen, Alexandre Reuben, Jadi M. Bohac +32 more

Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011458

N/A

0DataRank · unranked

5 citations

Young‐Hee Lee, Nathaniel Deboever, Marcelo V. Negrão, Hai T. Tran, Edwin Parra +17 more

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.005

N/A

0DataRank · unranked

460 citations

Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf +38 more

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.12.010

N/A

0DataRank · unranked

126 citations

Marcelo V. Negrão, Alexandre Reuben, Lorenzo Federico, Lixia Diao, Daniel J. McGrail +34 more

Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy

Clinical Lung Cancer(2020)10.1016/j.cllc.2019.11.003

N/A

0DataRank · unranked

114 citations

Apar Pataer, Ara A. Vaporciyan, Arlene M. Correa, Boris Sepesi, César A. Moran +10 more

Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.12.011

N/A

0DataRank · unranked

91 citations

Jianjun Zhang, Carol C. Wu, Hai T. Tran, Lerong Li, Lixia Diao +13 more

LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence

The Annals of Thoracic Surgery(2020)10.1016/j.athoracsur.2020.03.114

N/A

0DataRank · unranked

18 citations

Edwin R. Parra, Jiexin Zhang, David B. Nelson, Erin M. Corsini, Pamela Villalobos +22 more

Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities

Journal of Thoracic Disease(2020)10.21037/jtd.2020.01.42

N/A

0DataRank · unranked

8 citations

K. G. Mitchell, Jing Wang, Junya Fujimoto, Myrna C. B. Godoy, Carmen Behrens +16 more

Stephen G. Swisher

Indexed papers

Top data-sharing exemplar

Papers